newsfilter
← Latest News
Business Wire·

TYME Announces Appointment of John Rothman, Ph.D. to Executive Vice President, Product Development

BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME, an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced the appointment of John Rothman Ph.D. as Executive Vice President, Product Development.